District Court, Southern District of New York, No. Vintage Pharmaceuticals, a company that is now also part of Endo, also distributed the tablets under its brand, according to the lawsuit. Qualitest stopped distributing the fluoride tablets by October 2013.
In 2010 alone, New York paid out more than $984,000 in reimbursements to healthcare providers who submitted claims for the fluoride tablets for Medicaid beneficiaries, according to a lawsuit filed in the case by Manhattan U.S.
The settlement includes $5 million resolving claims related to New York's Medicaid program. The FDA and Endo, which bought Qualitest in 2010, confirmed those findings, according to Schneiderman. The misrepresentations came to light after a whistleblower, Stephan Porter, a dentist in Florida, tested tablets that Qualitest made between 20 and learned of the actual fluoride amounts, according to New York Attorney General Eric Schneiderman. The vitamins, in fact, contained half that amount, the attorney general said. Qualitest labeled and promoted that the vitamins contained an amount of fluoride recommended by the U.S. What's more, patients were exposed at higher risks of cavities and related health problems, the attorney general said. Qualitest's misleading labels caused healthcare professionals to submit false reimbursement claims to Medicaid and federal health care plans, who then paid for vitamins that did not contain the fluoride amount stated on the label, the New York attorney general said. A spokeswoman for Endo and the generic drug maker unit, Qualitest Pharmaceuticals, declined to comment. Department of Justice and state attorneys general later intervened. The case stemmed from a 2013 whistleblower lawsuit filed under the False Claims Act in which the U.S.
New York Attorney General Eric Schneiderman announced the settlement on Wednesday. (Endo), for deceptively marketing their powerful opioid, Opana, for more than a decade in Oregon. government and 47 states stemming from the unlawful labeling of multivitamins that contained fluoride. Oregon Attorney General Ellen Rosenblum today filed a lawsuit against opioid manufacturer, Endo Health Solutions and Endo Pharmaceuticals, Inc. By Suzanne Barlyn and Nate Raymond NEW YORK (Reuters) - A generic drug maker owned by Endo International Plc has reached a $39 million settlement with the U.S.
0 kommentar(er)
